Skip to main content

Table 3 Pharmaceutical epigenetic effects

From: The transposon-driven evolutionary origin and basis of histone deacetylase functions and limitations in disease prevention

Chemical

Reported epigenetic effect

Valproic acid

Histone deacetylase inhibition (Phiel et al. 2001)

5-Fluro-2′-deoxyuridine

DNA hypermethylation (Nyce et al. 1993)

Hydralazine

Inhibition of DNA methylation (Gorelik and Richardson 2009)

Procainamide

Inhibition of DNA methylation (Gorelik and Richardson 2009)

Retinoic acid

Reduction of DNA methylation (Kuriyama et al. 2008)

Methotrexate

Reduction of DNA methylation (Toffoli et al. 2003; Friso et al. 2002)

Suberoylanilide hydroxamic acid

Histone deacetylase inhibition (Duvic and Vu 2007)

Sodium butyrate

Histone deacetylase inhibition (Reuse et al. 2009)